The Hybrid Capture II test detects which of the following?

The Hybrid Capture II test detects which of the following?

• A. High risk groups for cervical cancer
• B. High risk and low groups for cervical cancer
• C. HPV high risk and low risk types, C. trachomatis and N. gonorrhoeae
• D. Cervical cancer screening only

Answer: (B)

Hybrid Capture II is designed to detect HPV DNA from both high‑risk and low‑risk HPV types in cervical samples. It uses separate probe sets to capture and signal the presence of high‑risk types (the ones most linked to cervical neoplasia) and low‑risk types (which are less like to progress to cancer). This dual detection provides information about HPV infection across the risk spectrum, helping assess cervical cancer risk. It does not detect cervical cancer by itself, and it does not test for other sexually transmitted organisms like Chlamydia trachomatis or Neisseria gonorrhoeae.

Hybrid Capture II is designed to detect HPV DNA from both high‑risk and low‑risk HPV types in cervical samples. It uses separate probe sets to capture and signal the presence of high‑risk types (the ones most linked to cervical neoplasia) and low‑risk types (which are less like to progress to cancer). This dual detection provides information about HPV infection across the risk spectrum, helping assess cervical cancer risk. It does not detect cervical cancer by itself, and it does not test for other sexually transmitted organisms like Chlamydia trachomatis or Neisseria gonorrhoeae.